Biomedical Engineering Reference
In-Depth Information
411. Sakamoto, J. H.; van de Ven, A. L.; Godin, B.; Blanco, E.; Serda, R. E.; Grattoni, A.;
Ziemys, A.; Bouamrani, A.; Hu, T.; Ranganathan, S. I.; De Rosa, E.; Martinez, J. O.; Smid, C. A.;
Buchanan, R.; Lee, S. Y.; Srinivasan, S.; Landry, M.; Meyn, A.; Tasciotti, E.; Li, X.;
Decuzzi, P.; Ferrari, M. Review: Enabling Individualized Therapy through Nanotechnology.
Pharm. Res.
2010,
62,
57-89.
412. Canal, P.; Gamelin, E.; Vassal, G.; Robert, J. Benefits of Pharmacological Knowledge in the
Design and Monitoring of Cancer Chemotherapy.
Pathol. Oncol. Res.
1998,
4,
171-178.
413. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges.
Nat. Rev. Cancer
2005,
5,
161-171.
414. Tallaj, J. A.; Franco, V.; Rayburn, B. K.; Pinderski, L.; Benza, R. L.; Pamboukian, S., et al.
Response of Doxorubicin Induced Cardiomyopathy to the Current Management Strategy of
Heart Failure.
J. Heart Lung Transplant
2005,
24,
196-201.
415. Rai, P.; Mallidi, S.; Zheng, X.; Rahmanzadeh, R.; Mir, Y.; Elrington, S.; Khurshid, A.; Hasan, T.
Development and Applications of Photo-Triggered Theranostic Agents.
Adv. Drug Deliv. Rev.
2010,
62,
1094-1124.
416. Shubayev, V. I.; Pisanic, T. R.; Jin, S. Magnetic Nanoparticles for Theragnostics.
Adv. Drug
Deliv. Rev
2009,
61,
467-477.
417. Borm, P. J.; Kreyling, W. Toxicological Hazards of Inhaled Nanoparticles-Potential Implica-
tions for Drug Delivery.
J. Nanosci. Nanotechnol.
2004,
4,
521-531.
418. Colvin, V. L. The Potential Environmental Impact of Engineered Nanomaterials.
Nat. Biotech-
nol.
2003,
21,
1166-1170.
419. Monteiro-Riviere, N. A.; Inman, A. O.; Zhang, L. W. Limitations and Relative Utility of
Screening Assays to Assess Engineered Nanoparticle Toxicity in a Human Cell Line.
Toxicol.
Appl. Pharmacol.
2009,
234,
222-235.
420. Murray, A. R.; Kisin, E.; Leonard, S. S.; Young, S. H.; Kommimeni, C.; Kagan, V. E., et al. In
vivo Immunological Toxicity in Mice of Carbon Nanotubes with Impurities.
Toxicology
2009,
257,
161-171.
421. Nel, A.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.;
Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-
Bio Interface.
Nat. Mater.
2009,
8,
543-557.
422. Oberdorster, E. Manufactured Nanomaterials (fullerenes, C60) Induce Oxidative Stress in the
Brain Of Juvenile Largemouth Bass.
Environ. Health Perspect.
2004,
1112,
1058-1062.
423. Oberdorster, E.; Zhu, S.; Blickley, T. M.; McClellan-Green, P.; Haasch, M. L. Ecotoxicology
of Carbon-based Engineered Nanoparticles: Effects of Fullerene (C
60
) on Aquatic Organisms.
Carbon
2006,
44,
1112-1120.
424. Sayes, C. M.; Fortner, J. D.; Guo, W.; Lyon, D.; Boyd, A. M.; Ausman, K. D.; Tao, Y. J.;
Sitharaman, B.; Wilson, L. J.; Hughes, J. B.; West, J. L.; Colvin, V. L. The Differential Cyto-
toxicity of Water-soluble Fullerenes.
Nano Lett.
2004,
4,
1881-1887.
425. Mukherjee, P.; Bhattacharya, R.; Wang, P.; Wang, L.; Basu, S.; Nagy, J. A.; Atala, A.; Muk-
hopadhyay, D.; Soker, S. Antiangiogenic Properties of Gold Nanoparticles.
Clin. Cancer
Res.
2005,
11,
3530-3534.
426. Czerniawska, A. Experimental Investigations on the Penetration of 198Au from Nasal Mucous
Membrane into Cerebrospinal Fluid.
Acta Otolaryngol.
1970,
70,
58-61.
427. Iscan, Y. Y.; Hekimoglu, S.; Kas, S.; Hinca, A. A.
Formulation and Characterization of Solid
Lipid Nanoparticles for Skin Delivery, Conference Lipid and Surfactant Dispersed Systems
.
Moscow, Proceedings Topic; , 1999, pp. 163-166.
428. Mahmoudi, M.; Shokrgozar, M. A.; Simchi, A.; Imani, M.; Milani, A. S.; Stroeve, P.; Vali, H.;
Hafeli, U. O.; Bonakdar, S. Multiphysics Flow Modeling and in Vitro Toxicity of Iron Oxide
Nanoparticles Coated with Poly(vinyl alcohol).
J. Phys. Chem. C
2009,
113,
2322-2331.
